LuYNiWQuX, et al.Spironolactone for preventing contrast-induced nephropathy after percutaneous coronary intervention in patients with acute myocardial infarction and chronic kidney disease. Angiology. 2025;76(10):969-980.
2.
SunGChenPWangK, et al.Contrast-induced nephropathy and long-term mortality after percutaneous coronary intervention in patients with acute myocardial infarction. Angiology. 2019;70(7):621-626.
3.
ToprakKKaplangorayMMemioğluT, et al. Comparative evaluation of intermountain risk score with Mehran risk score for risk estimation of contrast-induced nephropathy and short-term mortality in ST-segment elevation myocardial infarction patients. Angiology. 2023;00033197231201931.
4.
MehranRAymongEDNikolskyE, et al.A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol2004;44(7):1393-1399.
5.
Abellás-SequeirosRARaposeiras-RoubínSAbu-AssiE, et al.Mehran contrast nephropathy risk score: is it still useful 10 years later?J Cardiol. 2016;67(3):262-267.
6.
GayatEArrigoMLittnerovaS, et al.Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study. Eur J Heart Fail2018;20(2):345-354.
7.
PittBRemmeWZannadFEplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators, et al.Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309-1321.
8.
PittBZannadFRemmeWJ, et al.The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med. 1999;341(10):709-717.
9.
McDonaghTAMetraMAdamoMESC Scientific Document Group, et al.2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726.
10.
HeidenreichPABozkurtBAguilarD, et al.2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(17):e263-e421.
